| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A folylpoly-γ-glutamate synthase single nucleotide polymorphism associated with response to pemetrexed treatment combined with platinum for non-small cell lung cancer
|
Fukuda, Satoshi
|
|
2016
|
102 |
C |
p. 15-20
6 p.
|
artikel
|
| 2 |
Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
|
Lee, Sang Hoon
|
|
2016
|
102 |
C |
p. 89-95
7 p.
|
artikel
|
| 3 |
Clinical course of stage IV invasive mucinous adenocarcinoma of the lung
|
Cha, Yoon Jin
|
|
2016
|
102 |
C |
p. 82-88
7 p.
|
artikel
|
| 4 |
Clinical relevance of ROS1 rearrangements detection in advanced squamous cell carcinomas
|
Gibelin, Cécilia
|
|
2016
|
102 |
C |
p. 42-43
2 p.
|
artikel
|
| 5 |
Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs
|
Jiang, Juhong
|
|
2016
|
102 |
C |
p. 101-107
7 p.
|
artikel
|
| 6 |
Combination of cisplatin and lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma: Report of two cases
|
Metaxas, Yannis
|
|
2016
|
102 |
C |
p. 136-138
3 p.
|
artikel
|
| 7 |
Contents
|
|
|
2016
|
102 |
C |
p. iv-v
nvt p.
|
artikel
|
| 8 |
Corneal graft rejection in a patient treated with nivolumab for primary lung cancer
|
Le Fournis, S.
|
|
2016
|
102 |
C |
p. 28-29
2 p.
|
artikel
|
| 9 |
Drebrin: A new oncofetal biomarker associated with prognosis of lung adenocarcinoma
|
Iyama, Shinji
|
|
2016
|
102 |
C |
p. 74-81
8 p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2016
|
102 |
C |
p. iii-
1 p.
|
artikel
|
| 11 |
Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors
|
Levacq, Delphine
|
|
2016
|
102 |
C |
p. 38-41
4 p.
|
artikel
|
| 12 |
Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study
|
Wong, Melisa L.
|
|
2016
|
102 |
C |
p. 108-117
10 p.
|
artikel
|
| 13 |
Letter to the Editor
|
Martins, Stella Regina
|
|
2016
|
102 |
C |
p. 139-140
2 p.
|
artikel
|
| 14 |
Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
|
Chapman, Aaron M.
|
|
2016
|
102 |
C |
p. 122-134
13 p.
|
artikel
|
| 15 |
Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study)
|
Cicènas, Saulius
|
|
2016
|
102 |
C |
p. 30-37
8 p.
|
artikel
|
| 16 |
Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial
|
Hanna, Nasser H.
|
|
2016
|
102 |
C |
p. 65-73
9 p.
|
artikel
|
| 17 |
Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysis
|
Gupta, Arjun
|
|
2016
|
102 |
C |
p. 49-59
11 p.
|
artikel
|
| 18 |
Prognostic impact of pleural lavage cytology in patients with primary lung cancer
|
Tomizawa, Kenji
|
|
2016
|
102 |
C |
p. 60-64
5 p.
|
artikel
|
| 19 |
Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC
|
Agrawal, Vishesh
|
|
2016
|
102 |
C |
p. 1-8
8 p.
|
artikel
|
| 20 |
Report of two cases of pseudoprogression in patients with non–small cell lung cancer treated with nivolumab—including histological analysis of one case after tumor regression
|
Tanizaki, Junko
|
|
2016
|
102 |
C |
p. 44-48
5 p.
|
artikel
|
| 21 |
Response and acquired resistance to crizotinib in Chinese patients with lung adenocarcinomas harboring MET Exon 14 splicing alternations
|
Dong, Hua-Jie
|
|
2016
|
102 |
C |
p. 118-121
4 p.
|
artikel
|
| 22 |
Response to pemetrexed rechallenge after acquired resistance of ALK inhibitors
|
Miyazaki, Kunihiko
|
|
2016
|
102 |
C |
p. 135-
1 p.
|
artikel
|
| 23 |
RETRACTED: Kaiso is expressed in lung cancer: Its expression and localization is affected by p120ctn
|
Dai, Shun-Dong
|
|
2016
|
102 |
C |
p. 141-
1 p.
|
artikel
|
| 24 |
The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials
|
Li, Bob T.
|
|
2016
|
102 |
C |
p. 21-27
7 p.
|
artikel
|
| 25 |
The challenge of molecular testing for clinical trials in advanced non-small cell lung cancer patients: Analysis of a prospective database
|
Vrancken, Anniek
|
|
2016
|
102 |
C |
p. 96-100
5 p.
|
artikel
|
| 26 |
Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer
|
Halvorsen, Tarje Onsøien
|
|
2016
|
102 |
C |
p. 9-14
6 p.
|
artikel
|
Tijdschrift beschrijving